{"result": {"id": "4f8b1f20-a382-4e81-aaae-928f1d61ce60", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>ABPM<|>EVENT<|>Ambulatory Blood Pressure Monitoring, a method to track blood pressure over 24 hours>  \n##  \n(\"entity\"<|>HBPM<|>EVENT<|>Home Blood Pressure Monitoring, a method for patients to measure their own blood pressure>  \n##  \n(\"entity\"<|>ADRENAL CORTEX<|>ORGANIZATION<|>The adrenal cortex is the outer part of the adrenal gland that produces hormones like aldosterone>  \n##  \n(\"entity\"<|>HYPERTENSION<|>EVENT<|>A chronic medical condition characterized by elevated blood pressure>  \n##  \n(\"entity\"<|>RESISTANT HYPERTENSION<|>EVENT<|>Hypertension that remains uncontrolled despite treatment with three antihypertensive drugs>  \n##  \n(\"relationship\"<|>ABPM<|>HYPERTENSION<|>ABPM is used to diagnose and monitor hypertension<|>8>  \n##  \n(\"relationship\"<|>HBPM<|>HYPERTENSION<|>HBPM helps in the long-term management of hypertension<|>7>  \n##  \n(\"relationship\"<|>ADRENAL CORTEX<|>PRIMARY ALDOSTERONISM<|>The adrenal cortex overproduces aldosterone in primary aldosteronism<|>9>  \n##  \n(\"relationship\"<|>PRIMARY ALDOSTERONISM<|>HYPERTENSION<|>Primary aldosteronism is a leading cause of secondary hypertension<|>9>  \n##  \n(\"relationship\"<|>RESISTANT HYPERTENSION<|>PRIMARY ALDOSTERONISM<|>Primary aldosteronism is a common cause of resistant hypertension<|>8>  \n##  \n(\"relationship\"<|>HYPERTENSION<|>OSAS<|>OSAS is a risk factor for and can exacerbate hypertension<|>7>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558802, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 435, "prompt_tokens": 3042, "total_tokens": 3477, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2944}, "prompt_cache_hit_tokens": 2944, "prompt_cache_miss_tokens": 98}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 耐受者\n外科手术\t上气道手术 减重手术\t非严重肥胖的中度或轻度 OSAS;扁桃体Ⅱ度及以上肥大的重度 OSAS 有合并症的严重肥胖患者\n　　注 :OSAS为阻塞性睡眠呼吸暂停综合征;MAD为下颌适度前移矫治器;PAP为气道正压通气;CPAP为持续气道正压通气;autoCPAP为全自 动持续气道正压通气;BiPAP为双水平气道正压通气;autoBiPAP为全自动双水平气道正压通气;COPD为慢性阻塞性肺疾病。\n\n\n　　　(1) 患者评估 :建议在应用容易引起血压升高的药  物之前对患者进行评估 。特别是对患者心血管疾病的  风险进行评估[702] 。检测患者血压、心率、既往慢性疾  病史、家族性心血管疾病史及生化检测包括肾脏功能、 电解质等方面 ,根据患者的危险分层权衡该类药物的  使用 , 并 在 用 药 期 间 监 测 血 压 ( 包 括  ABPM 和  HBPM) 。对于既往有高血压病史患者 ,尽管短期服用  该类药物也需监测血压。\n　　　(2)停用引发血压升高的药物 :对于明确诊断为药 物诱发高血压的患者 ,可暂停口服该类药物 。多数患 者停用药物后血压可恢复正常 。必须使用该类药物 时 ,可小剂量应用该药物或使用对血压影响较小的其 他同类药物。\n　　　(3)改善生活方式 :所有血压升高患者均应注意改 善生活习惯 ,如低盐饮食、戒烟限酒、控制体重等[703] 。\n　　　(4) 降压药的应用 :药物引起血压升高幅度较大 , 停药后患者仍出现头痛、头晕等不适症状者 ,可考虑加 用降压药 。对于无法停用该类药物的患者则需考虑联 合降压药治疗 。应合理选择降压药(表 29) 。对于本 身为难治性高血压患者 ,应尽量避免使用升高血压的 药物。\n10.5  原发性醛固酮增多症\n　10.5.1  流行病学与临床特征   原发性醛固酮增多症 是肾上腺皮质球状带自主分泌过多醛固酮 ,不受高钠 负荷抑制 ,导致高血压、高醛固酮、肾素活性受抑制为\n\n\n　主要表现的临床综合征 。其在高血压人群中占 5%~ 15%[704]  ,是最常见的继发性高血压之一 。有研究显 示在新诊断的高血压患者中 ,原发性醛固酮增多症的 患病率为 4.1%[705]  ,且患病率随着血压水平的升高而 增高 ,在难治性高血压中约占 20%[704] 。\n　　原发性醛�\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>OSAS<|>EVENT<|>Obstructive Sleep Apnea Syndrome, a condition involving repeated episodes of upper airway obstruction during sleep>  \n##  \n(\"entity\"<|>MAD<|>EVENT<|>Mandibular Advancement Device, a treatment for mild to moderate OSAS by repositioning the jaw to keep the airway open>  \n##  \n(\"entity\"<|>PAP<|>EVENT<|>Positive Airway Pressure, a therapy for OSAS that uses air pressure to keep the airway open>  \n##  \n(\"entity\"<|>CPAP<|>EVENT<|>Continuous Positive Airway Pressure, a specific type of PAP therapy for severe OSAS>  \n##  \n(\"entity\"<|>autoCPAP<|>EVENT<|>Automatic Continuous Positive Airway Pressure, an adaptive form of CPAP therapy>  \n##  \n(\"entity\"<|>BiPAP<|>EVENT<|>Bilevel Positive Airway Pressure, a therapy for OSAS that adjusts pressure during inhalation and exhalation>  \n##  \n(\"entity\"<|>autoBiPAP<|>EVENT<|>Automatic Bilevel Positive Airway Pressure, an adaptive form of BiPAP therapy>  \n##  \n(\"entity\"<|>COPD<|>EVENT<|>Chronic Obstructive Pulmonary Disease, a chronic inflammatory lung disease often comorbid with OSAS>  \n##  \n(\"entity\"<|>PRIMARY ALDOSTERONISM<|>EVENT<|>A hormonal disorder causing high blood pressure due to excessive aldosterone production by the adrenal glands>  \n##  \n(\"relationship\"<|>OSAS<|>MAD<|>MAD is a treatment option for mild to moderate OSAS<|>7>  \n##  \n(\"relationship\"<|>OSAS<|>PAP<|>PAP therapies (CPAP, BiPAP, etc.) are primary treatments for OSAS<|>9>  \n##  \n(\"relationship\"<|>CPAP<|>autoCPAP<|>autoCPAP is an advanced version of CPAP with automatic pressure adjustment<|>8>  \n##  \n(\"relationship\"<|>BiPAP<|>autoBiPAP<|>autoBiPAP is an advanced version of BiPAP with automatic pressure adjustment<|>8>  \n##  \n(\"relationship\"<|>OSAS<|>COPD<|>OSAS and COPD often coexist, requiring combined management strategies<|>6>  \n##  \n(\"relationship\"<|>PRIMARY ALDOSTERONISM<|>OSAS<|>Both conditions are linked to hypertension, though via different mechanisms<|>4>  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_2be359974bb93839bb3e79cde78cebc55dd26d1acd4233330b36c4aa27eea640_v2"}